ISIvy Anne Sebastian

Ivy Anne Sebastian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ivy Anne Sebastian has a total of 147 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Global Health Perspective on the 2026 AHA/ASA Stroke Guidelines: Lessons from the Indian Health System

    by Priyanka Boettger, Ayush Agarwal, Omar Alhaj Omar, Martin Juenemann, Samuel Sossalla, Michael Buerke, Emmanuel Carrera, Ivy Anne Sebastian, Jeyaraj D. Pandian, Padmavathy Narayanan Sylaja

    Background: Contemporary evidence-based guidelines have substantially improved outcomes after acute ischemic stroke in well-resourced health systems. However, their implementation remains uneven in low- and middle-income countries (LMICs), where infrastructure, specialist workforce, financing, and time-critical workflows often differ from the assumptions embedded in guideline development. The extent to which high-income reference guidelines can be translated into resource-constrained settings therefore requires systematic evaluation. Summary: We conducted a structured systems-level review of the 2026 American Heart Association/American Stroke Association guideline for the early management of acute ischemic stroke, using India as an illustrative LMIC case. Acute implementation-relevant recommendations were grouped into clinically coherent clusters across eight domains of care and assessed using a predefined capacity-burden framework covering infrastructure and technology requirements, specialist workforce intensity, workflow complexity and time sensitivity, and financial or consumable dependency. Recommendation clusters were classified as directly implementable, adaptable, or infrastructure-constrained. Feasibility varied substantially across domains. Low-burden components, including stroke awareness, prehospital assessment, prenotification, stroke severity assessment, dysphagia screening, glucose monitoring, and pragmatic blood pressure protocols, were largely directly implementable. Moderate-capacity recommendations, including non-contrast computed tomography-first triage, protocolized intravenous thrombolysis, telestroke support, interhospital transfer agreements, and organized stroke-unit principles, were generally adaptable through service redesign, task-sharing, protocolization, and regional referral models. In contrast, advanced perfusion imaging, mobile stroke units, comprehensive thrombectomy pathways, and endovascular thrombectomy remained predominantly infrastructure constrained. The Indian case demonstrated similar feasibility gradients, while highlighting persistent rural-urban, public-private, and financing-related inequities. Key Messages: Many contemporary acute ischemic stroke guideline components can be implemented or adapted in resource-constrained health systems when translated according to available system capacity. The principal barrier to equitable stroke outcomes is not the absence of evidence but the misalignment between guideline assumptions and real-world infrastructure, workforce, financing, and workflow capacity. A capacity-burden approach offers a pragmatic framework for prioritizing stroke interventions, distinguishing immediately scalable components from those requiring service redesign or longer-term investment, and supporting more equitable global stroke care.

  • The World Stroke Organization future leaders program: Building leadership capacity in global stroke care

    by Leonardo Augusto Carbonera, Ana Cláudia de Souza, Vasileios-Arsenios Lioutas, Jatinder S Minhas, Ivy Sebastian, Ahmed Nasreldein, Julia Shapranova, Hugh Markus, Christopher Chen, Werner Hacke, et al.

    Background: Leadership development is essential to advancing stroke care globally. The World Stroke Organization (WSO) Future Stroke Leaders Program (FSLP) was established to identify and support global early-career professionals in stroke care worldwide. The program offers structured leadership training, mentorship, and seed funding for implementation projects. Selection criteria prioritize diversity, leadership potential, and institutional support. The article describes the design and implementation of the WSO FSLP and evaluates its contribution to stroke care advancement, professional development, and global collaboration. Methods: This is a descriptive narrative of the WSO FSLP, based on program documentation, participant surveys, and public databases. Programmatic key performance indicators (KPIs) aligned with WSO’s strategic goals were used to track impact. Results: Among 56 participants in the first two cohorts, selected from over 35 countries, engagement with the WSO FSLP contributed to improved access to and delivery of care by developing stroke services in underserved areas, enhancing publication output, and supporting active involvement in international policy and advocacy efforts. Participants reported career advancement, increased research engagement, and expanded collaborative networks as a direct result of their participation in the program. Conclusions: The WSO FSLP is a model for developing global stroke leadership. Its impact spans clinical innovation, academic research, and policy influence, guiding implementation. Continued program adaptation to the changing international landscape, alumni engagement, and long-term impact evaluation will help sustain and scale worldwide contributions to stroke care equity.


  • COSMOS: Interrater and Intrarater Reliability Study of a Novel Outcome Measure

    by Mayank Goyal, Aravind Ganesh, Salome L. Bosshart, Alexander Stebner, Nishita Singh, Bijoy K. Menon, Shelagh B. Coutts, Johanna M. Ospel, Mohammed A. Almekhlafi, Julie Kromm, et al.

    The vast majority of patients with minor stroke achieve what are considered good or excellent outcomes on the modified Rankin Scale (0–1/0–2), yet many are dissatisfied with their outcomes. There is a need for a functional outcome measure tailored for minor stroke that better reflects the spectrum of clinical outcomes within this population. We developed the Canadian Outcome Scale for Minor Stroke (COSMOS) and performed an interrater and intrarater reliability study. COSMOS is a 7-point scale ranging from 0 (no symptoms) to 6 (loss of independence for an instrumental or basic activity of daily living or worse), which accounts for performance limitations and losses of a person’s hobbies or passions and of their employment, educational, service, or caregiving pursuits, besides just activities of daily living. One hundred test case vignettes were developed. Stroke physicians, fellows, and research nurses/staff were invited to review training materials and provide the COSMOS grade for 20 cases representing all COSMOS grades (0–6). After a minimum 2 weeks’ wash-out period, participants were asked to grade the same 20 cases again. Interrater and intrarater agreement were assessed using Cohen κ, weighted κ, percentage agreement, and intraclass correlation coefficient. Among 33 participants (18 attending physicians, 9 stroke fellows, and 6 research staff/nurses; median 12.5 years of experience), COSMOS had substantial interrater reliability (80.5% agreement [95% CI, 75.7%–85.3%]; Cohen κ, 0.77 [95% CI, 0.72–0.84]) and almost-perfect intrarater reliability overall (87.1% agreement [95% CI, 84.4%–89.7%]; Cohen κ, 0.85 [95% CI, 0.82–0.88]); weighted κ showed almost perfect agreement for both interrater (0.88 [95% CI, 0.85–0.92]) and intrarater reliability (0.92 [95% CI, 0.90–0.94]). The overall chance-adjusted simultaneous intrarater/interrater agreement using intraclass correlation coefficient was 0.95 (95% CI, 0.94–0.97). Results were similar with substantial to almost-perfect agreement when considering key subgroups based on position (attendings, fellows, research nurses/staff) and years of experience. In conclusion, the newly proposed COSMOS scale demonstrated substantial interrater and intrarater reliability. The scale merits further study in cohort studies and clinical trials of minor stroke.


  • Patient and Caregiver Perspectives on the Design and Execution of ACT-GLOBAL, a Stroke Adaptive Platform Trial: A Focus Group Study

    by Aravind Ganesh, Nora D. Cristall, Brian Dewar, Michael D. Hill, Carol Kenney, Ivy A. Sebastian, Rose Wilson, Craig S. Anderson, Xiaoying Chen, Bijoy Menon, et al.

    Introduction: Adaptive platform trials represent a paradigm shift in stroke research. We examined how patient-partners perceived the design and execution of an international platform trial in acute stroke, ACT-GLOBAL (A multi-faCtorial, mulTi-arm, multi-staGe, randomized, gLOBal Adaptive pLatform trial for stroke), through a series of focus groups with process evaluation methodology. Methods: Participants were recruited from two comprehensive stroke centers one in Calgary, Canada and one in Sydney, Australia. Four virtual focus groups were attended by a total of 21 patient-partners and 11 clinician-researchers. One focus group had repeat attendees to review a draft consent form and patient information sheet, and one presented a video describing platform trials. Physician facilitators presented the platform trial concept followed by a facilitated discussion. Audio recordings were transcribed and combined with field notes. Exemplar quotes and themes were identified separately for each group and subsequently across groups. Results: Patients/caregivers perceived acute stroke-focused adaptive platform trials such as ACT-GLOBAL as providing potentially beneficial opportunities to be randomized to multiple treatments, with efficiencies and richer data to improve patient care. Emphasis was given to the importance of gatekeeper processes for the addition of future questions posed by the platform to ensure examined questions would not interfere with routine care, and that safety decisions were ultimately made by nonconflicted parties. They appreciated that deferral of consent would be ideal to allow timely randomization/treatment within the adaptive stroke platform, and for patient safety to be prioritized in enrolment-related decisions with family input whenever feasible. The need to have trial information accessible in digestible chunks, multiple languages, and modalities was emphasized. To facilitate engagement, transparency, trust, and two-way communication was deemed critical to the informed consent process. Conclusion: Patient-partners were supportive of an adaptive platform trial design. However, they expressed important priorities in their execution while safeguarding patient autonomy and safety. Oversight, multiple modes of delivering patient information, and having feedback evaluation and transparency with ongoing participation were identified as valued components. Deferral of consent was recognized as a pragmatic way to enroll patients. Similar considerations may apply to adaptive platform trials in other neurological/medical emergencies.


  • Comparing Stroke Profiles and Outcomes between Urban and Rural India: A Secondary Analysis of the SPRINT INDIA Trial

    by Shweta Jain Verma, Arya Devi Karuthedathu Mana Sanal Kumar, Deepti Arora, Aneesh Dhasan, Padmavathyamma Narayanapillai Sylaja, Dheeraj Khurana, Pamidimukkala Vijaya, Biman Kanti Ray, Vivek Nambiar, Sanjith Aaron, et al.

    Introduction: Stroke causes significant death and disability, with urban-rural disparities in healthcare and limited studies in India, despite its rural majority of 70%. The post hoc study aimed to explore differences in stroke profiles, risk factors, and outcomes between urban and rural participants using data from the Secondary Prevention by Structured Semi-Interactive Stroke Prevention Package in India (SPRINT INDIA) trial. Methods: The SPRINT INDIA trial was a multi-center randomized clinical trial across 31 Indian sites. Data were collected between April 28, 2018, and November 30, 2021. Index stroke patients, aged 18 and older, presenting within 2 days to 3 months of symptom onset, were randomized using a centralized web-based system into intervention or control groups. The intervention included SMS, videos, and an interactive educational workbook for secondary stroke prevention in 11 Indian languages. Baseline data captured in a case report form included participants’ urban or rural locations. The primary outcome was a composite endpoint that included recurrent stroke, high-risk transient ischemic attack (TIA), acute coronary syndrome (ACS), and all-cause mortality within 1 year after randomization. The trial is registered by Clinicaltrials.gov (NCT03228979) and Clinical Trials Registry-India (CTRI/2017/09/009600). Results: The trial enrolled 4,298 sub-acute stroke patients, out of which 3,038 (70.68%) were followed up, of which 1,620 (53.32%) were urban and 1,418 (46.68%) were rural. The primary composite outcome (recurrent stroke, high-risk TIA, ACS, and mortality) was higher in urban areas compared to rural areas (61 [3.8%] vs. 34 [2.4%]; p = 0.018) at 1-year follow-up. All cases of high-risk TIA occurred in urban participants (p < 0.001). Urban participants were more educated (795 [49.1%] vs. rural 394 [27.8%]; p < 0.001), with higher rates of dyslipidemia (335 [20.7%] vs. 247 [17.4%]; p = 0.023), and higher body mass index (25.17 ± 4.31 vs. 24.76 ± 4.23; p = 0.008). Behavioral risk factors of alcohol intake and smoking tobacco were higher in rural patients compared to urban patients (65 [4.6%] vs. 73 [4.5%]; p < 0.001 and 59 [4.2%] vs. 65 [4.0%]; p < 0.001, respectively). Conclusion: Urban patients show higher stroke recurrence and lifestyle-related conditions, while rural patients face more behavioral risks like smoking and alcohol use. To address these disparities, requires targeted interventions; urban patients would benefit from lifestyle-focused programs, such as dietary improvements and stress management. For rural patients, programs should focus on reducing behavioral risks like smoking and alcohol use through community-based education and accessible cessation support services.


  • Strategies to Advance Stroke Care in Women: An International Conversation

    by Eman M. Khedr, Ghada Al-Attar, Julieta Rosales, Gisele Sampaio Silva, Ivy Anne Sebastian, Karen D. Orjuela, Ana Cláudia de Souza


  • Impact of Sex and Gender in Stroke in South and Southeast Asia: A Rapid Scoping Review

    by Rinita Mascarenhas, Dorcas B.C. Gandhi, Jaime Angeles Sesgundo, Veena Babu, Vinita Elizabeth Mani, Ivy Anne Sebastian

    Background: South Asia and Southeast Asia account for more than 40% of the global stroke burden, with differences in stroke risk factors, mortality, and outcomes compared to high-income countries. Sociocultural norms compound the preexisting biological risk differences, resulting in a disproportionate burden of stroke in women in this region. This review summarizes the sex and gender differences across the stroke care continuum in South Asia and Southeast Asia over the past 20 years. Summary: Despite a higher incidence of stroke in men than women in South and Southeast Asia, women have greater stroke severity and poorer outcomes after stroke. Higher levels of premorbid disability and poor physical health at baseline may be contributory. There is a high prevalence of vascular risk factors such as hypertension, dyslipidemia, cardiac sources of embolism, as well as metabolic syndrome and insulin resistance, among the women in this region. Smoking is uncommon among women; however, other forms of smokeless tobacco, such as tobacco leaf and betel nut chewing, are more prevalent, especially in the rural areas in these countries. Women are more likely to have delayed presentations to the hospital due to untimely recognition of stroke symptoms; however, with regards to door-to-needle times or intravenous thrombolysis (IVT) rates, we found equivocal data. Wide gaps exist in stroke awareness and healthcare-seeking behaviors, with women more commonly opting for public hospitals and low-cost wards, more likely to discontinue treatment, and less likely to adhere to poststroke rehabilitation. Key Findings: This review exposes the gender lacunae in stroke service provision across South Asia and Southeast Asia while acknowledging the many knowledge gaps in our understanding. Although the biological risk differences are non-modifiable, educational, policy, and economic measures to mitigate sociocultural barriers are much needed in the region. Sound epidemiological data are needed from more countries to better understand these differences and bridge this gap. It is imperative to advocate and implement policies and programs for stroke care viable for women, cognizant of the gender and cost bias, as well as the interplay of social and cultural structures specific to the regions.


  • Fostering a Culture of Research: From Recommendations to Implementation

    by Ivy Anne Sebastian, Ana Claudia de Souza, Meron Awraris Gebrewold, Dorcas B.C. Gandhi, Vanessa Cano-Nigenda, Caleb Ferguson, Mehari Gebreyohanns, Vasileios-Arsenios Lioutas


  • Open Access

    Stroke systems of care in South-East Asia Region (SEAR): commonalities and diversities

    by Ivy A. Sebastian, Dorcas B.C. Gandhi, Padmavati N. Sylaja, Raju Paudel, Yogeshwar V. Kalkonde, Yangchen Yangchen, Harsha Gunasekara, Ranjit J. Injety, Pranay J. Vijayanand, Nistara S. Chawla, et al.


  • Developing a Second Line of Physician Leaders

    by Ivy Anne Sebastian, Dorcas B.C. Gandhi, Raviteja Kakarla, Atul Phillips